These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The mode of action of sulpiride as an atypical antidepressant agent. Jenner P; Marsden CD Adv Biochem Psychopharmacol; 1982; 32():85-103. PubMed ID: 7046370 [TBL] [Abstract][Full Text] [Related]
25. Changes in dopaminergic and glutamatergic excitatory mechanisms of micturition reflex after middle cerebral artery occlusion in conscious rats. Yokoyama O; Yoshiyama M; Namiki M; de Groat WC Exp Neurol; 2002 Jan; 173(1):129-35. PubMed ID: 11771945 [TBL] [Abstract][Full Text] [Related]
26. Evidence that systemically administered dopamine antagonists activate dopamine neuron firing primarily by blockade of somatodendritic autoreceptors. Pucak ML; Grace AA J Pharmacol Exp Ther; 1994 Dec; 271(3):1181-92. PubMed ID: 7996424 [TBL] [Abstract][Full Text] [Related]
28. Dopamine D2 receptors mediate glomerular hyperfiltration due to amino acids. Luippold G; Mühlbauer B J Pharmacol Exp Ther; 1998 Sep; 286(3):1248-52. PubMed ID: 9732385 [TBL] [Abstract][Full Text] [Related]
29. Intestinal pharmacomanometry and glucose tolerance: two kinds of dopaminergic mechanisms in the human. Lechin F; van der Dijs B Acta Gastroenterol Latinoam; 1981; 11(2):247-59. PubMed ID: 7039203 [TBL] [Abstract][Full Text] [Related]
30. Chronic sulpiride treatment produces supersensitivity of striatal adenylate cyclase to dopamine in sexually immature or adult castrated rats. Gnegy ME; Bernabei A; Treisman G J Pharmacol Exp Ther; 1983 Mar; 224(3):627-33. PubMed ID: 6827485 [TBL] [Abstract][Full Text] [Related]
31. Effect of the novel T-selective calcium channel antagonist mibefradil on kidney function in comparison with amlodipine. Greven J Arzneimittelforschung; 1998 Aug; 48(8):806-10. PubMed ID: 9748707 [TBL] [Abstract][Full Text] [Related]
33. Effects of dopamine on kidney function. Schoeppe W Proc R Soc Med; 1977; 70 Suppl 2(Suppl 2):36-42. PubMed ID: 233752 [No Abstract] [Full Text] [Related]
34. Expression and pharmacological characterization of the human D3 dopamine receptor. Freedman SB; Patel S; Marwood R; Emms F; Seabrook GR; Knowles MR; McAllister G J Pharmacol Exp Ther; 1994 Jan; 268(1):417-26. PubMed ID: 8301582 [TBL] [Abstract][Full Text] [Related]
35. Dopamine receptor mechanism(s) and antinociception and tolerance induced by swim stress in formalin test. Fazli-Tabaei S; Yahyavi SH; Nouri M; Zartab H; Javid G; Loghavi S; Zarrindast MR Behav Pharmacol; 2006 Jun; 17(4):341-7. PubMed ID: 16914952 [TBL] [Abstract][Full Text] [Related]
36. Intestinal pharmacomanometry and glucose tolerance: evidence for two antagonistic dopaminergic mechanisms in the human. Lechin F; van der Dijs B Biol Psychiatry; 1981 Oct; 16(10):969-86. PubMed ID: 7306619 [TBL] [Abstract][Full Text] [Related]
37. Sulpiride and mnemonic function: effects of a dopamine D2 receptor antagonist on working memory, emotional memory and long-term memory in healthy volunteers. Mehta MA; Hinton EC; Montgomery AJ; Bantick RA; Grasby PM J Psychopharmacol; 2005 Jan; 19(1):29-38. PubMed ID: 15671126 [TBL] [Abstract][Full Text] [Related]
38. [Menopause and its treatment]. Delecour M; Lemaire-Warembourg B Sem Hop; 1980 Oct 18-25; 56(39-40):1593-4. PubMed ID: 6255575 [No Abstract] [Full Text] [Related]
39. Side-effects of benzamide derivatives. Benazzi F Int J Geriatr Psychiatry; 1997 Jan; 12(1):132. PubMed ID: 9050439 [No Abstract] [Full Text] [Related]
40. Dopamine in the hepatorenal syndrome. Wilson JR JAMA; 1977 Dec; 238(25):2719-20. PubMed ID: 579213 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]